DCGI orders recall of 45 medications for quality issues, with 5 identified as spurious.
India's drug regulator, the DCGI, has ordered the recall of 45 medications for failing quality standards. Reports of 50 banned "fake" medicines were clarified as incorrect; only five were identified as spurious. The CDSCO tests around 2,000 samples monthly, with 40-50 failing various parameters. The regulator is taking action against the makers of the spurious drugs and continues to work on improving compliance under the Drug and Cosmetics Act.
October 09, 2024
3 Articles